These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1021 related items for PubMed ID: 16707748
21. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK. N Engl J Med; 1998 Apr 16; 338(16):1112-8. PubMed ID: 9545359 [Abstract] [Full Text] [Related]
22. Home oxygen therapy after preterm birth in Western Australia. Saletti A, Stick S, Doherty D, Simmer K. J Paediatr Child Health; 2004 Apr 16; 40(9-10):519-23. PubMed ID: 15367144 [Abstract] [Full Text] [Related]
23. Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth. Doyle LW, Ranganathan S, Cheong JLY. Am J Respir Crit Care Med; 2017 Nov 15; 196(10):1318-1324. PubMed ID: 28707987 [Abstract] [Full Text] [Related]
24. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS, Caffeine for Apnea of Prematurity (CAP) Trial Investigators. JAMA; 2012 Jan 18; 307(3):275-82. PubMed ID: 22253394 [Abstract] [Full Text] [Related]
30. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, Odrezin GT, Cutter GR, Kirklin JK, Pacifico AD. N Engl J Med; 1989 Jun 08; 320(23):1511-6. PubMed ID: 2498657 [Abstract] [Full Text] [Related]
31. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Schmidt B. Biol Neonate; 2005 Jun 08; 88(3):208-13. PubMed ID: 16210843 [Abstract] [Full Text] [Related]
38. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470 [Abstract] [Full Text] [Related]
39. Impact of delivery room resuscitation on outcomes up to 18 months in very low birth weight infants. DeMauro SB, Roberts RS, Davis P, Alvaro R, Bairam A, Schmidt B, Caffeine for Apnea of Prematurity Trial Investigators. J Pediatr; 2011 Oct 12; 159(4):546-50.e1. PubMed ID: 21592510 [Abstract] [Full Text] [Related]